These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30317733)
1. [Comparison of epidermal growth factor receptor gene mutation in lung adenocarcinoma using biopsied tissue, pleural effusion and blood samples]. Shi Y; Ma ZP; Cui WL; Pang XL; Zhang W; Ma YQ Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):775-779. PubMed ID: 30317733 [No Abstract] [Full Text] [Related]
2. Comparison of Epidermal Growth Factor Receptor Gene Mutations Identified Using Pleural Effusion and Primary Tumor Tissue Samples in Non-Small Cell Lung Cancer. Liu N; Sun RZ; Du J; Dong QZ; Fan CF; Li QC; Wang EH; Liu Y Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):e44-e51. PubMed ID: 28800007 [TBL] [Abstract][Full Text] [Related]
3. EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy. Guo H; Wan Y; Tian G; Liu Q; Kang Y; Li Y; Yao Z; Lin D Oncol Rep; 2012 Mar; 27(3):880-90. PubMed ID: 22134479 [TBL] [Abstract][Full Text] [Related]
4. Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples. Guan Y; Wang ZJ; Wang LQ; Hua DF; Liu J Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173189 [TBL] [Abstract][Full Text] [Related]
5. [Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis: A Single-center Retrospective Study]. Yin W; Zhang H; Gu Y; Yi F; Li Q; Liu Y; Yao Y; Liu Z; Cao B Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):156-166. PubMed ID: 35340158 [TBL] [Abstract][Full Text] [Related]
6. Survival of lung adenocarcinoma patients with malignant pleural effusion. Wu SG; Yu CJ; Tsai MF; Liao WY; Yang CH; Jan IS; Yang PC; Shih JY Eur Respir J; 2013 Jun; 41(6):1409-18. PubMed ID: 23018906 [TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA. Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536 [TBL] [Abstract][Full Text] [Related]
8. A Combined test using both cell sediment and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients. Kawahara A; Fukumitsu C; Azuma K; Taira T; Abe H; Takase Y; Murata K; Sadashima E; Hattori S; Naito Y; Akiba J Cytopathology; 2018 Apr; 29(2):150-155. PubMed ID: 29363841 [TBL] [Abstract][Full Text] [Related]
9. Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma. Tsai TH; Wu SG; Chang YL; Wu CT; Tsai MF; Wei PF; Yang CH; Yu CJ; Yang PC; Shih JY J Thorac Oncol; 2012 Jun; 7(6):993-1000. PubMed ID: 22525557 [TBL] [Abstract][Full Text] [Related]
10. Predicting outcomes of EGFR-targeted therapy in non-small cell lung cancer patients using pleural effusions samples and peptide nucleic acid probe assay. Wang MC; Wang CL; Chen TL; Chang JW; Lu JJ; Chang PY; Chiou CC Clin Chem Lab Med; 2017 Oct; 55(12):1979-1986. PubMed ID: 28787267 [TBL] [Abstract][Full Text] [Related]
11. Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma. Wu SG; Gow CH; Yu CJ; Chang YL; Yang CH; Hsu YC; Shih JY; Lee YC; Yang PC Eur Respir J; 2008 Oct; 32(4):924-30. PubMed ID: 18508816 [TBL] [Abstract][Full Text] [Related]
12. Cell HE staining smears and paired cell paraffin sections in detection of epithelial growth factor receptor gene of pleural fluid specimens. Hou F; Qi C; Lu Y; Li F; Hao Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):35-44. PubMed ID: 35545361 [TBL] [Abstract][Full Text] [Related]
13. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655 [TBL] [Abstract][Full Text] [Related]
14. Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma. Zhang P; Wu X; Tang M; Nie X; Li L Thorac Cancer; 2019 Dec; 10(12):2218-2224. PubMed ID: 31602787 [TBL] [Abstract][Full Text] [Related]
15. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients. Zhao C; Li X; Su C; Li J; Cheng N; Ren S; Chen X; Zhou C Int J Clin Exp Pathol; 2015; 8(3):3104-9. PubMed ID: 26045824 [TBL] [Abstract][Full Text] [Related]
17. EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6. Wu YL; Sequist LV; Hu CP; Feng J; Lu S; Huang Y; Li W; Hou M; Schuler M; Mok T; Yamamoto N; O'Byrne K; Hirsh V; Gibson N; Massey D; Kim M; Yang JC Br J Cancer; 2017 Jan; 116(2):175-185. PubMed ID: 28006816 [TBL] [Abstract][Full Text] [Related]
18. Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. Paliogiannis P; Attene F; Cossu A; Defraia E; Porcu G; Carta A; Sotgiu MI; Pazzola A; Cordero L; Capelli F; Fadda GM; Ortu S; Sotgiu G; Palomba G; Sini MC; Palmieri G; Colombino M Mol Med Rep; 2015 Jul; 12(1):187-91. PubMed ID: 25683726 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between EGFR Mutations and Pathological Classification and Specimen of Lung Adenocarcinoma]. Kang L; Zheng J; Zhu X Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):382-388. PubMed ID: 28641695 [TBL] [Abstract][Full Text] [Related]
20. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens. Asaka S; Yoshizawa A; Matsuda K; Yamaguchi A; Yamamoto H; Shiina T; Nakata R; Ogawa K; Zhang M; Honda T Oncol Rep; 2017 Feb; 37(2):1020-1026. PubMed ID: 27922678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]